Question 1

What is the catalog number for XR8-69?

Accepted Answer

The catalog number for XR8-69 is orb1687114.

Question 2

What sizes are available for XR8-69?

Accepted Answer

XR8-69 is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does XR8-69 come in?

Accepted Answer

XR8-69 is available in 3 different pack sizes.

Question 4

Is XR8-69 in stock?

Accepted Answer

XR8-69 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is XR8-69 used for?

Accepted Answer

XR8-69 is a small-molecule inhibitor targeting the SARS-CoV-2 papain-like protease (PLpro), exhibiting low micromolar antiviral activity in infected human cell cultures. This compound is a useful research tool for studying coronavirus replication and the potential of host-directed antiviral strategi

Question 6

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 7

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 8

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

XR8-69

Product Specifications

Field of Research

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Compound N008-0008

Compound N008-0008

BODIPY 630/650X

BODIPY 630/650X

Linavonkibart Biosimilar - Anti-TGFB1 mAb - Research Grade

Linavonkibart Biosimilar - Anti-TGFB1 mAb - Research Grade